Beta Bionics BBNX
NASDAQ BBNX
$17.42 -1.91 (-9.88%)
As of: Sep 9, 2026 · 3:59 PM EDT

Beta Bionics (BBNX) Cash from Investing Activities (QoQ) (2024 - 2026)

Analysis

Beta Bionics (BBNX) Cash from Investing Activities (QoQ) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Beta Bionics 786.45 Mn 605.96 Mn 18.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.33%
Mar 31, 2026 3,219.00%
Dec 31, 2025 -93.06%
Sep 30, 2025 53.67%
Jun 30, 2025 103.45%
Mar 31, 2025 -503.88%
Dec 31, 2024 -294.61%
Sep 30, 2024 361.88%
Jun 30, 2024 -56.83%